Takeda Settles for $13.6 Million Over Alleged Kickbacks to Physicians
The pharmaceutical giant Takeda Pharmaceuticals has agreed to a $13.6 million settlement concerning allegations of providing kickbacks to doctors for prescribing its antidepressant.
Editorial Staff
1 min read
Updated 6 days ago
Takeda Pharmaceuticals has reached a settlement of $13.6 million in response to allegations that it incentivized physicians to prescribe one of its antidepressants.
The settlement, announced on May 15, 2026, addresses concerns regarding the company's practices related to kickbacks.
This case highlights ongoing scrutiny within the pharmaceutical industry regarding the ethics of incentivizing medical prescriptions.